Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.

Agabio R, Sinclair JM, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Heydtman M, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, de Beaurepaire R, Leggio L.

Lancet Psychiatry. 2018 Dec;5(12):957-960. doi: 10.1016/S2215-0366(18)30303-1. Epub 2018 Nov 6. No abstract available.

PMID:
30413394
2.

Pharmacokinetic Studies of Baclofen Are Not Sufficient to Establish an Optimized Dosage for Management of Alcohol Disorder.

Simon N, Franchitto N, Rolland B.

Front Psychiatry. 2018 Oct 5;9:485. doi: 10.3389/fpsyt.2018.00485. eCollection 2018. Review.

3.

[The serotonin syndrome: An updated literature review].

Jurek L, Nourredine M, Megarbane B, d'Amato T, Dorey JM, Rolland B.

Rev Med Interne. 2018 Sep 19. pii: S0248-8663(18)30699-4. doi: 10.1016/j.revmed.2018.08.010. [Epub ahead of print] French.

PMID:
30243558
4.

How to Manage Self-Poisoning With Baclofen in Alcohol Use Disorder? Current Updates.

Franchitto N, Rolland B, Pelissier F, Simon N.

Front Psychiatry. 2018 Sep 4;9:417. doi: 10.3389/fpsyt.2018.00417. eCollection 2018. Review.

5.

Full-Profile Pharmacokinetic Study of High Dose Baclofen in Subjects With Alcohol Use Disorder.

Simon N, Moirand R, Dematteis M, Bordet R, Deplanque D, Rolland B.

Front Psychiatry. 2018 Aug 23;9:385. doi: 10.3389/fpsyt.2018.00385. eCollection 2018.

6.

Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused Review.

Rolland B, Simon N, Franchitto N.

Front Psychiatry. 2018 Aug 22;9:367. doi: 10.3389/fpsyt.2018.00367. eCollection 2018. Review.

7.

Psychiatric comorbidities associated with a positive screening using the Montreal Cognitive Assessment (MoCA) test in subjects with severe alcohol use disorder.

D'Hondt F, Lescut C, Maurage P, Menard O, Gibour B, Cottencin O, Montègue S, Jardri R, Rolland B.

Drug Alcohol Depend. 2018 Oct 1;191:266-269. doi: 10.1016/j.drugalcdep.2018.07.009. Epub 2018 Aug 22.

PMID:
30153608
8.

Searching for Survivor-Specific Services at NCI-Designated Comprehensive Cancer Centers: A Qualitative Assessment.

Rolland B, Eschler J.

J Natl Compr Canc Netw. 2018 Jul;16(7):839-844. doi: 10.6004/jnccn.2018.7019.

PMID:
30006426
9.

Animal models of binge drinking, current challenges to improve face validity.

Jeanblanc J, Rolland B, Gierski F, Martinetti MP, Naassila M.

Neurosci Biobehav Rev. 2018 May 5. pii: S0149-7634(18)30123-4. doi: 10.1016/j.neubiorev.2018.05.002. [Epub ahead of print] Review.

PMID:
29738795
10.

Influence of comorbid alcohol use disorders on the clinical patterns of major depressive disorder: A general population-based study.

Carton L, Pignon B, Baguet A, Benradia I, Roelandt JL, Vaiva G, Thomas P, Amad A, De Timary P, Naassila M, Geoffroy PA, Rolland B.

Drug Alcohol Depend. 2018 Jun 1;187:40-47. doi: 10.1016/j.drugalcdep.2018.02.009. Epub 2018 Mar 23.

PMID:
29626745
11.

Prevalence and predictors of no lifetime utilization of mental health treatment among people with mental disorders in France: findings from the 'Mental Health in General Population' (MHGP) survey.

Font H, Roelandt JL, Behal H, Geoffroy PA, Pignon B, Amad A, Simioni N, Vaiva G, Thomas P, Duhamel A, Benradia I, Rolland B.

Soc Psychiatry Psychiatr Epidemiol. 2018 Jun;53(6):567-576. doi: 10.1007/s00127-018-1507-0. Epub 2018 Apr 4.

PMID:
29619580
12.

Compared characteristics of current vs. past smokers at the time of diagnosis of a first-time lung or head and neck cancer: a cross-sectional study.

Vannimenus C, Bricout H, Le Rouzic O, Mouawad F, Chevalier D, Dansin E, Rotsaert L, Lefebvre G, Cottencin O, Porte H, Scherpereel A, El Fahsi A, Richard F, Rolland B; ALTAK Study Group.

BMC Cancer. 2018 Apr 3;18(1):372. doi: 10.1186/s12885-018-4253-5.

13.

Increased prevalence of anxiety disorders in third-generation migrants in comparison to natives and to first-generation migrants.

Pignon B, Amad A, Pelissolo A, Fovet T, Thomas P, Vaiva G, Roelandt JL, Benradia I, Rolland B, Geoffroy PA.

J Psychiatr Res. 2018 Jul;102:38-43. doi: 10.1016/j.jpsychires.2018.03.007. Epub 2018 Mar 20.

PMID:
29597072
14.

[Consultation/liaison addiction medicine: Tools and specificities].

Poloméni P, Cleirec G, Icard C, Ramos A, Rolland B.

Encephale. 2018 Sep;44(4):354-362. doi: 10.1016/j.encep.2017.12.007. Epub 2018 Mar 24. French.

PMID:
29580705
15.

The need for patient-tailored dosing of baclofen in future clinical trials.

Costa M, Rolland B, Carrieri P.

Eur Neuropsychopharmacol. 2018 May;28(5):656-657. doi: 10.1016/j.euroneuro.2018.03.001. Epub 2018 Mar 16. No abstract available.

PMID:
29551439
16.

[Authors' response].

Rolland B, Authier N, Brousse G, Bouhassira D, Perrot S, Dematteis M.

Rev Med Interne. 2018 Jun;39(6):447-448. doi: 10.1016/j.revmed.2018.02.006. Epub 2018 Mar 8. French. No abstract available.

PMID:
29526326
17.

Evaluation by undergraduate medical students of a role-playing training program on the management of acute states of agitation.

Rolland B, Fovet T, Poissy J, Eichholtzer C, Lesage M, Thomas P, Jourdain M.

Encephale. 2018 Apr;44(2):101-105. doi: 10.1016/j.encep.2017.09.009. Epub 2017 Dec 22.

PMID:
29275981
18.

A latent class analysis of psychotic symptoms in the general population.

Pignon B, Peyre H, Szöke A, Geoffroy PA, Rolland B, Jardri R, Thomas P, Vaiva G, Roelandt JL, Benradia I, Behal H, Schürhoff F, Amad A.

Aust N Z J Psychiatry. 2018 Jun;52(6):573-584. doi: 10.1177/0004867417744255. Epub 2017 Dec 13.

PMID:
29232967
19.

Binge Eating, But Not Other Disordered Eating Symptoms, Is a Significant Contributor of Binge Drinking Severity: Findings from a Cross-Sectional Study among French Students.

Rolland B, Naassila M, Duffau C, Houchi H, Gierski F, André J.

Front Psychol. 2017 Oct 30;8:1878. doi: 10.3389/fpsyg.2017.01878. eCollection 2017.

20.

On-the-ground application of the 'temporary recommendation for use' regulatory measure on off-label use of baclofen for alcohol dependence in France: a regional survey of community pharmacies.

Auffret M, Rolland B, Caous AS, Gaboriau L, Deheul S, Bordet R, Gautier S.

Fundam Clin Pharmacol. 2018 Apr;32(2):234-238. doi: 10.1111/fcp.12332. Epub 2017 Dec 6.

PMID:
29143356
21.

On the Facilitation of Collaborative Research: Enter Stage Left, the Consortium Director.

Rolland B, Potter JD.

Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1581-1582. doi: 10.1158/1055-9965.EPI-17-0471. No abstract available.

22.

The Role of General Practitioners in the 2015 French Guidelines on Alcohol Misuse.

Rolland B, Naassila M, Paille F, Aubin HJ; Société Française d’Alcoologie.

Alcohol Alcohol. 2017 Nov 1;52(6):747-748. doi: 10.1093/alcalc/agx054. No abstract available.

PMID:
29016709
23.

Thirty- Versus Ten-Day Diazepam Treatment for Alcohol Detoxification and a Comparison of Drinking Patterns, Craving, and Anxiety for up to 12 Weeks: A "Proof-of-Concept" Open-Label Randomized Controlled Trial.

Simioni N, Labreuche J, Behal H, Cottencin O, Rolland B.

J Clin Psychopharmacol. 2017 Dec;37(6):722-728. doi: 10.1097/JCP.0000000000000786.

PMID:
28984747
24.

A study in the general population about sadness to disentangle the continuum from well-being to depressive disorders.

Tebeka S, Pignon B, Amad A, Le Strat Y, Brichant-Petitjean C, Thomas P, Vaiva G, Roelandt JL, Benradia I, Etain B, Rolland B, Dubertret C, Geoffroy PA.

J Affect Disord. 2018 Jan 15;226:66-71. doi: 10.1016/j.jad.2017.08.085. Epub 2017 Sep 21.

PMID:
28963866
25.

Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model.

Wright N, Reimer J, Somaini L, Roncero C, Maremmani I, Simon N, Krajci P, Littlewood R, D'Agnone O, Alho H, Rolland B.

Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1206-1214. doi: 10.1097/MEG.0000000000000962. Review.

PMID:
28914697
26.

Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine.

Lescut C, Gaboriau L, Carton L, Rolland B.

J Clin Psychopharmacol. 2017 Oct;37(5):631-633. doi: 10.1097/JCP.0000000000000763. No abstract available.

PMID:
28806388
27.

Severity of Baclofen Self-Poisoning Linked to Psychiatric Co-morbidity in Alcohol-Dependent Patients: Better Measurement of Risk and Benefit.

Pelissier F, de Haro L, Rolland B, Franchitto N.

Basic Clin Pharmacol Toxicol. 2017 Oct;121(4):217-219. doi: 10.1111/bcpt.12832. Epub 2017 Jul 10. No abstract available.

28.

Sociodemographic and clinical correlates of psychotic symptoms in the general population: Findings from the MHGP survey.

Pignon B, Schürhoff F, Szöke A, Geoffroy PA, Jardri R, Roelandt JL, Rolland B, Thomas P, Vaiva G, Amad A.

Schizophr Res. 2018 Mar;193:336-342. doi: 10.1016/j.schres.2017.06.053. Epub 2017 Jul 8.

PMID:
28689754
29.

The dose-effect relationship of baclofen in alcohol dependence: A 1-year cohort study.

Pignon B, Labreuche J, Auffret M, Gautier S, Deheul S, Simioni N, Cottencin O, Bordet R, Duhamel A, Rolland B.

Hum Psychopharmacol. 2017 Jul;32(4). doi: 10.1002/hup.2593. Epub 2017 May 18.

PMID:
28517239
30.

Alcohol Use Disorders and Immigration up to the Third Generation in France: Findings from a 39,617-Subject Survey in the General Population.

Rolland B, Geoffroy PA, Pignon B, Benradia I, Font H, Roelandt JL, Amad A.

Alcohol Clin Exp Res. 2017 Jun;41(6):1137-1143. doi: 10.1111/acer.13387. Epub 2017 May 2.

PMID:
28470666
31.

Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study.

Louvet A, Labreuche J, Artru F, Bouthors A, Rolland B, Saffers P, Lollivier J, Lemaître E, Dharancy S, Lassailly G, Canva-Delcambre V, Duhamel A, Mathurin P.

Hepatology. 2017 Nov;66(5):1464-1473. doi: 10.1002/hep.29240. Epub 2017 Sep 26.

PMID:
28459138
32.

Comparison between the WHO and NIAAA criteria for binge drinking on drinking features and alcohol-related aftermaths: Results from a cross-sectional study among eight emergency wards in France.

Rolland B, Chazeron I, Carpentier F, Moustafa F, Viallon A, Jacob X, Lesage P, Ragonnet D, Genty A, Geneste J, Poulet E, Dematteis M, Llorca PM, Naassila M, Brousse G.

Drug Alcohol Depend. 2017 Jun 1;175:92-98. doi: 10.1016/j.drugalcdep.2017.01.034. Epub 2017 Mar 23.

PMID:
28411560
33.

Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.

Franchitto N, Jullian B, Salles J, Pelissier F, Rolland B.

Expert Opin Drug Metab Toxicol. 2017 Jun;13(6):669-677. doi: 10.1080/17425255.2017.1312340. Epub 2017 Apr 3. Review.

PMID:
28343423
34.

[Misuse and dependence on prescription opioids: Prevention, identification and treatment].

Rolland B, Bouhassira D, Authier N, Auriacombe M, Martinez V, Polomeni P, Brousse G, Schwan R, Lack P, Bachellier J, Rostaing S, Bendimerad P, Vergne-Salle P, Dematteis M, Perrot S.

Rev Med Interne. 2017 Aug;38(8):539-546. doi: 10.1016/j.revmed.2016.12.024. Epub 2017 Feb 15. Review. French.

PMID:
28214183
35.

Binge Drinking: Current Diagnostic and Therapeutic Issues.

Rolland B, Naassila M.

CNS Drugs. 2017 Mar;31(3):181-186. doi: 10.1007/s40263-017-0413-4.

PMID:
28205146
36.

Bread wheat milling behavior: effects of genetic and environmental factors, and modeling using grain mechanical resistance traits.

Oury FX, Lasme P, Michelet C, Dubat A, Gardet O, Heumez E, Rolland B, Rousset M, Abecassis J, Bar L'Helgouac'h C, Lullien-Pellerin V.

Theor Appl Genet. 2017 May;130(5):929-950. doi: 10.1007/s00122-017-2861-0. Epub 2017 Feb 15.

PMID:
28204843
37.

Authors' Reply to Alain Braillon's Comment on "Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: An example with baclofen and alcohol dependence in France''.

Auffret M, Labreuche J, Duhamel A, Deheul S, Cottencin O, Bordet R, Gautier S, Rolland B.

Drug Saf. 2017 Apr;40(4):361-362. doi: 10.1007/s40264-017-0513-6. No abstract available.

PMID:
28188600
38.

Prevalence and clinical severity of mood disorders among first-, second- and third-generation migrants.

Pignon B, Geoffroy PA, Thomas P, Roelandt JL, Rolland B, Morgan C, Vaiva G, Amad A.

J Affect Disord. 2017 Mar 1;210:174-180. doi: 10.1016/j.jad.2016.12.039. Epub 2016 Dec 27.

PMID:
28049102
39.

Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.

Auffret M, Labreuche J, Duhamel A, Deheul S, Cottencin O, Bordet R, Gautier S, Rolland B.

Drug Saf. 2017 Mar;40(3):257-262. doi: 10.1007/s40264-016-0489-7.

PMID:
27988884
40.

Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol.

Rolland B, Auffret M, Labreuche J, Lapeyre-Mestre M, Dib M, Kemkem A, Grit I, Drelon M, Duhamel A, Cabe N, Vabret F, Guillin O, Baguet A, Masquelier C, Dervaux A, Deheul S, Bordet R, Carton L, Cottencin O, Jardri R, Gautier S.

Expert Opin Drug Saf. 2017 Feb;16(2):125-132. doi: 10.1080/14740338.2017.1270939. Epub 2016 Dec 21.

PMID:
27984918
41.

Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.

Marcus PM, Pashayan N, Church TR, Doria-Rose VP, Gould MK, Hubbard RA, Marrone M, Miglioretti DL, Pharoah PD, Pinsky PF, Rendle KA, Robbins HA, Roberts MC, Rolland B, Schiffman M, Tiro JA, Zauber AG, Winn DM, Khoury MJ.

Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1449-1455. Epub 2016 Aug 9.

42.

Characteristics of Patients with Alcohol Dependence Seeking Baclofen Treatment in France: A Two-Centre Comparative Cohort Study.

Simioni N, Preda C, Deken V, Bence C, Cottencin O, Rolland B.

Alcohol Alcohol. 2016 Nov;51(6):664-669. Epub 2016 Mar 17.

PMID:
26988996
43.

Stratifying delays for assessment by type of substance to improve the probability of attendance in outpatient services.

Simioni N, Rolland B, Labreuche J, Ramdane N, Cottencin O.

Drug Alcohol Depend. 2016 Sep 1;166:187-93. doi: 10.1016/j.drugalcdep.2016.07.012. Epub 2016 Jul 20.

PMID:
27465970
44.

Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.

Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju ShN, Wormser D, Gao P, Kaptoge S, Berrington de Gonzalez A, Cairns BJ, Huxley R, Jackson ChL, Joshy G, Lewington S, Manson JE, Murphy N, Patel AV, Samet JM, Woodward M, Zheng W, Zhou M, Bansal N, Barricarte A, Carter B, Cerhan JR, Smith GD, Fang X, Franco OH, Green J, Halsey J, Hildebrand JS, Jung KJ, Korda RJ, McLerran DF, Moore SC, O'Keeffe LM, Paige E, Ramond A, Reeves GK, Rolland B, Sacerdote C, Sattar N, Sofianopoulou E, Stevens J, Thun M, Ueshima H, Yang L, Yun YD, Willeit P, Banks E, Beral V, Chen Zh, Gapstur SM, Gunter MJ, Hartge P, Jee SH, Lam TH, Peto R, Potter JD, Willett WC, Thompson SG, Danesh J, Hu FB.

Lancet. 2016 Aug 20;388(10046):776-86. doi: 10.1016/S0140-6736(16)30175-1. Epub 2016 Jul 13.

45.

Buprenorphine dosing choices in specific populations: review of expert opinion.

Maremmani I, Rolland B, Somaini L, Roncero C, Reimer J, Wright N, Littlewood R, Krajci P, Alho H, D'Agnone O, Simon N.

Expert Opin Pharmacother. 2016 Sep;17(13):1727-31. doi: 10.1080/14656566.2016.1209486. Epub 2016 Aug 2. Review.

PMID:
27376622
46.

Factors Affecting the Agreement Between Emergency Psychiatrists and General Practitioners Regarding Involuntary Psychiatric Hospitalizations.

Geoffroy PA, Duhamel A, Behal H, Zouitina-Lietaert N, Duthilleul J, Marquette L, Ducrocq F, Vaiva G, Rolland B.

Sci Rep. 2016 Jun 21;6:28134. doi: 10.1038/srep28134.

47.

[Comparison of the concept of "responsibility" in neuroscience and in French criminal law: A cross-literature review for the psychiatric forensic practice].

Galland D, Jonas C, Jardri R, Wilquin M, Cottencin O, Thomas P, Rolland B.

Presse Med. 2016 Jun;45(6 Pt 1):559-66. doi: 10.1016/j.lpm.2016.03.018. Epub 2016 May 30. Review. French.

PMID:
27256973
48.

The 2015 French guidelines on alcohol misuse, issued in partnership with the European Federation of Addiction Societies: a focus on children and adolescents.

Rolland B, Paille F, Mann K, Aubin HJ.

Eur Child Adolesc Psychiatry. 2016 Oct;25(10):1145-8. doi: 10.1007/s00787-016-0874-x. Epub 2016 May 30. No abstract available.

PMID:
27240598
49.

Does baclofen have antidepressant qualities?

Geoffroy PA, Rolland B.

Encephale. 2016 Aug;42(4):384-5. doi: 10.1016/j.encep.2016.04.001. Epub 2016 May 20. No abstract available.

PMID:
27216595
50.

[Investigation of the medical and social situation of patients managed by opiate replacement regimens for over 10 years by their GP].

Messaadi N, Favre J, Rolland B, Cottencin O, Calafiore M, Stalnikiewicz B, Berkhout C.

Therapie. 2016 Oct;71(5):439-446. doi: 10.1016/j.therap.2016.01.011. Epub 2016 Apr 11. French.

PMID:
27203162

Supplemental Content

Loading ...
Support Center